Blogs

Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Resource Types

Electrochemical cell design: Turning electron transfer into a practical synthetic tool
Explore electrochemical cell design, electron transfer, process development, and scalable pharmaceutical synthesis. Read the article.
10th Jul, 2026
Read
What semi-targeted integration changes in biologics development
See how semi-targeted integration can improve cell line development, reduce clone screening, and support biologics development. Read the article.
8th Jul, 2026
Read
India as a Global CRDMO Powerhouse: Debunking Quality Myths
Explore how India’s CRDMO quality systems, regulatory scrutiny, and biologics manufacturing capabilities challenge outdated quality myths. Read more.
8th Jul, 2026
Read
Oligonucleotide Analytical Development: Five Hidden Traps and How to Avoid Them
Avoid five analytical traps in oligonucleotide development, from impurity profiling to bioanalysis and validation. Read more.
8th Jul, 2026
Read
Allometric scaling vs PBPK: when each approach helps in human dose prediction
Compare allometric scaling and PBPK for human dose prediction using in vivo data and mechanistic models. Read more.
23rd Jun, 2026
Read
From PBPK modeling to first-in-human dose: how predictive DMPK can reduce early clinical risk
Explore how PBPK modeling supports human PK prediction, first-in-human dose selection, and model-informed drug development. Read more.
23rd Jun, 2026
Read
Engineering Oral Solid Dosage Forms to Enhance Therapeutic Efficiency & Patient Acceptability
Explore how Syngene improves bioavailability, extended release and patient adherence in oral solid dosage forms. Watch the webinar.
23rd Jun, 2026
Read
Clinical development planning in India: From execution hub to strategic trial partner
Explore clinical development planning in India for scalable global trials, integrated execution, and submission-ready evidence. Read more.
15th Jun, 2026
Read
Supply chain resilience in multi-continent biopharma manufacturing
See how multi-continent biologics manufacturing supports supply chain resilience through tech transfer, regulatory readiness, and networked delivery. Read more.
15th Jun, 2026
Read
Future-Ready QC Labs in Pharma 4.0: How Automation, Biometrics, and VR Are Redefining Quality Standards in India
See how pharma 4.0 is reshaping QC labs in India through automation, biometrics, and VR for stronger digital quality control. Read more.
28th May, 2026
Read